Sorrento Therapeutics Inc (SRNE)
0.016
0.00 (0.00%)
USD |
OTCM |
May 06, 15:56
Sorrento Therapeutics Cash from Operations (Quarterly): -55.66M for June 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -55.66M |
| March 31, 2023 | -49.46M |
| December 31, 2022 | -68.34M |
| September 30, 2022 | -61.17M |
| June 30, 2022 | -80.99M |
| March 31, 2022 | -83.36M |
| December 31, 2021 | -72.14M |
| September 30, 2021 | -83.11M |
| June 30, 2021 | -78.52M |
| March 31, 2021 | -48.06M |
| December 31, 2020 | -40.87M |
| September 30, 2020 | -42.59M |
| June 30, 2020 | -37.52M |
| March 31, 2020 | -38.55M |
| December 31, 2019 | -36.02M |
| September 30, 2019 | -45.83M |
| June 30, 2019 | -46.83M |
| March 31, 2019 | -44.31M |
| December 31, 2018 | -44.98M |
| September 30, 2018 | -20.70M |
| June 30, 2018 | -22.12M |
| March 31, 2018 | -23.96M |
| December 31, 2017 | -44.85M |
| September 30, 2017 | -12.66M |
| June 30, 2017 | -19.75M |
| Date | Value |
|---|---|
| March 31, 2017 | -21.91M |
| December 31, 2016 | -16.52M |
| September 30, 2016 | -22.05M |
| June 30, 2016 | -12.18M |
| March 31, 2016 | -20.19M |
| December 31, 2015 | -16.16M |
| September 30, 2015 | -18.36M |
| June 30, 2015 | 1.295M |
| March 31, 2015 | -8.847M |
| December 31, 2014 | -7.656M |
| September 30, 2014 | -5.596M |
| June 30, 2014 | -6.388M |
| March 31, 2014 | -9.124M |
| December 31, 2013 | -7.211M |
| September 30, 2013 | -2.981M |
| June 30, 2013 | -3.815M |
| March 31, 2013 | -2.482M |
| December 31, 2012 | -1.329M |
| September 30, 2012 | -0.9994M |
| June 30, 2012 | -0.6713M |
| March 31, 2012 | -0.7976M |
| December 31, 2011 | -0.539M |
| September 30, 2011 | -0.5904M |
| June 30, 2011 | -1.186M |
| March 31, 2011 | -0.4277M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-83.36M
Minimum
Mar 2022
-36.02M
Maximum
Dec 2019
-57.00M
Average
-49.46M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Scilex Holding Co | -5.39M |
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.14M |
| Cash from Financing (Quarterly) | 88.81M |
| Free Cash Flow | -243.21M |
| Free Cash Flow Per Share (Quarterly) | -0.1012 |
| Free Cash Flow to Equity (Quarterly) | -126.87M |
| Free Cash Flow to Firm (Quarterly) | -53.11M |